More recently, acetylcholinesterase inhibitors, used in the treatment of AD, have been reported to enhance the intrinsic action of ACh on nicotinic receptors, thus supporting a role for nAChRs in preventing neurodegeneration. The gene discussed is ACHE; the disease is Alzheimer disease.